MedTrace Logo

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

NCT03501576 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-02-11

No results posted yet for this study

Summary

This clinical trial evaluates the influenza virus vaccination in evaluating human immune response in patients with lymphoma. Evaluating immune response may increase the understanding of how the immune system changes when patients receive treatment for lymphomas by looking at the antibody levels and the level of the different cells that make up the immune system over time compared to those without lymphoma.

Conditions

Interventions

BIOLOGICAL

Inactivated Influenza Vaccine

Given seasonal inactivated influenza vaccine IM

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Andres Chang, MD, PhD · Emory University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-06
Primary Completion
2026-05-26
Completion
2026-05-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03501576 on ClinicalTrials.gov